Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations

Table 2

Determinants of histidine-rich glycoprotein serum levels in lung cancer patients.

	Simple regression		Multiple regression
	Lung cancer patients
	0.09	0.27	-0.13	<0.001	0.19
CLT	-0.41	<0.001	-0.42
Fibrinogen	-0.18	0.03	-0.15
Stage IIIAB/LD lung cancer patients
	-0.09	0.71	-0.09	0.014	0.17
CLT	-0.41	0.001	-0.44
Fibrinogen	-0.09	0.48	-0.00
Stage IV/ED lung cancer patients
	0.28	0.008	0.07	<0.001	0.26
CLT	-0.5	<0.001	-0.46
Fibrinogen	-0.18	0.09	-0.06

: fibrin clot permeability coefficient; CLT: clot lysis time; LD: limited disease; ED: extensive disease.